Proteomics in thyroid tumor research

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 8, 2009, Pages 2717-2724

  Krause, Kerstin ^a   Jeßnitzer, Beate ^a   Fuhrer, Dagmar ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA;

ACETYLATION; AMINO ACID SUBSTITUTION; CANCER RESEARCH; CARCINOGENESIS; GENE EXPRESSION; HUMAN; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; THYROID DISEASE; THYROID TUMOR; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 68549085146     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0308     Document Type: Review

References (58)

1. Castro MR, Gharib H 2005 Continuing controversies in the management of thyroid nodules. Ann Intern Med 142:926-931
2. Hegedüs L 2004 Clinical practice. The thyroid nodule. N Engl J Med 351:1764-1771
3. Giuffrida D, Gharib H 1995 Controversies in the management of cold, hot, and occult thyroid nodules. Am J Med 99:642-650
4. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn 2nd GW, Tallini G, Kroll TG, Nikiforov YE 2003 RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318-2326
5. Wu G, Mambo E, Guo Z, Hu S, Huang X, Gollin SM, Trink B, Ladenson PW, Sidransky D, Xing M 2005 Uncommon mutation, but common amplifications, of the PIK3CA gene in thyroid tumors. J Clin Endocrinol Metab 90:4688-4693
6. Wilkins MR, Pasquali C, Appel RD, Ou K, Golaz O, Sanchez JC, Yan JX, Gooley AA, Hughes G, Humphery-Smith I, Williams KL, Hochstrasser DF 1996 From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis. Biotechnology (NY) 14:61-65
7. Chen G, Gharib TG, Huang CC, Taylor JM, Misek DE, Kardia SL, Giordano TJ, Iannettoni MD, Orringer MB, Hanash SM, Beer DG 2002 Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1:304-313
8. Wright Jr GL 2002 SELDI protein chip MS: a platform for biomarker discovery and cancer diagnosis. Expert Rev Mol Diagn 2:549-563
9. Wang J, Zhang X, Ge X, Guo H, Xiong G, Zhu Y 2008 Proteomic studies of early-stage and advanced ovarian cancer patients. Gynecol Oncol 111:111-119
10. Brozkova K, Budinska E, Bouchal P, Hernychova L, Knoflickova D, Valik D, Vyzula R, Vojtesek B, Nenutil R 2008 Surface-enhanced laser desorption/ionization time-of-flight proteomic profiling of breast carcinomas identifies clinicopathologically relevant groups of patients similar to previously defined clusters from cDNA expression. Breast Cancer Res 10:R48
11. Han KQ, Huang G, Gao CF, Wang XL, Ma B, Sun LQ, Wei ZJ 2008 Identification of lung cancer patients by serum protein profiling using surface enhanced laser desorption/ionization time-of-flight mass spectrometry. Am J Clin Oncol 31:133-139
12. Geng X, Wang F, Li YG, Zhu GP, Zhang WM 2007 SELDI-TOF MS protein chip technology for screening of serum markers of HBV-induced hepatocellular carcinoma. J Exp Clin Cancer Res 26:505-508
13. De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J 2009 Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. Lung Cancer 63:410-417
14. Diamandis EP 2004 Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics 3:367-378
15. Chen WG, White FM 2004 Proteomic analysis of cellular signaling. Expert Rev Proteomics 1:343-354
16. Gingras AC, Gstaiger M, Raught B, Aebersold R 2007 Analysis of protein complexes using mass spectrometry. Nat Rev Mol Cell Biol 8:645-654
17. Tekirian TL, Thomas SN, Yang A 2007 Advancing signaling networks through proteomics. Expert Rev Proteomics 4:573-583
18. Hibi K, Takahashi T, Sekido Y, Ueda R, Hida T, Ariyoshi Y, Takagi H, Takahashi T 1991 Coexpression of the stem cell factor and the c-kit genes in small-cell lung cancer. Oncogene 6:2291-2296
19. Bharti A, Ma PC, Maulik G, Singh R, Khan E, Skarin AT, Salgia R 2004 Haptoglobin α-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. Anticancer Res 24:1031-1038
20. Bader AG, Kang S, Zhao L, Vogt PK 2005 Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5:921-929
21. Ciampi R, Nikiforov YE 2007 RET/PTC rearrangements and BRAF mutations in thyroid tumorigenesis. Endocrinology 148:936-941
22. Paes JE, Ringel MD 2008 Dysregulation of the phosphatidylinositol 3-kinase pathway in thyroid neoplasia. Endocrinol Metab Clin North Am 37:375-387, viii-ix
23. Blagoev B, Kratchmarova I, Ong SE, Nielsen M, Foster LJ, Mann M 2003 A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling. Nat Biotechnol 21:315-318
24. Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M 2005 Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science 308:1472-1477
25. Blagoev B, Mann M 2006 Quantitative proteomics to study mitogen-activated protein kinases. Methods 40:243-250
26. Lilley KS, Friedman DB 2004 All about DIGE: quantification technology for differential-display 2D-gel proteomics. Expert Rev Proteomics 1:401-409
27. Lecocq R, Lamy F, Dumont JE 1979 Pattern of protein phosphorylation in intact stimulated cells: thyrotropin and dog thyroid. Eur J Biochem 102:147-152
28. Lecocq R, Lamy F, Dumont JE 1990 Use of two-dimensional gel electrophoresis and autoradiography as a tool in cell biology: the example of the thyroid and the liver. Electrophoresis 11:200-212
29. Krause K, Schierhorn A, Sinz A, Wissmann JD, Beck-Sickinger AG, Paschke R, Fuhrer D 2006 Toward the application of proteomics to human thyroid tissue. Thyroid 16:1131-1143
30. Marouga R, David S, Hawkins E 2005 The development of the DIGE system: 2D fluorescence difference gel analysis technology. Anal Bioanal Chem 382:669-678
31. Eszlinger M, Krohn K, Paschke R 2001 Complementary DNA expression array analysis suggests a lower expression of signal transduction proteins and receptors in cold and hot thyroid nodules. J Clin Endocrinol Metab 86:4834-4842
32. Eszlinger M, Krohn K, Frenzel R, Kropf S, Tönjes A, Paschke R 2004 Gene expression analysis reveals evidence for inactivation of the TGF-β signaling cascade in autonomously functioning thyroid nodules. Oncogene 23:795-804
33. Eszlinger M, Krohn K, Berger K, Läuter J, Kropf S, Beck M, Führer D, Paschke R 2005 Gene expression analysis reveals evidence for increased expression of cell cycle-associated genes and Gq-protein-protein kinase C signaling in cold thyroid nodules. J Clin Endocrinol Metab 90:1163-1170
34. Lacroix L, Lazar V, Michiels S, Ripoche H, Dessen P, Talbot M, Caillou B, Levillain JP, Schlumberger M, Bidart JM 2005 Follicular thyroid tumors with the PAX8-PPARγ1 rearrangement display characteristic genetic alterations. Am J Pathol 167:223-231
35. Chevillard S, Ugolin N, Vielh P, Ory K, Levalois C, Elliott D, Clayman GL, El-Naggar AK 2004 Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. Clin Cancer Res 10:6586-6597
36. Finley DJ, Zhu B, Barden CB, Fahey 3rd TJ 2004 Discrimination of benign and malignant thyroid nodules by molecular profiling. Ann Surg 240:425-436; discussion 436-437
37. Weber F, Shen L, Aldred MA, Morrison CD, Frilling A, Saji M, Schuppert F, Broelsch CE, Ringel MD, Eng C 2005 Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. J Clin Endocrinol Metab 90:2512-2521
38. Barden CB, Shister KW, Zhu B, Guiter G, Greenblatt DY, Zeiger MA, Fahey 3rd TJ 2003 Classification of follicular thyroid tumors by molecular signature: results of gene profiling. Clin Cancer Res 9:1792-1800
39. Mazzanti C, Zeiger MA, Costouros NG, Umbricht C, Westra WH, Smith D, Somervell H, Bevilacqua G, Alexander HR, Libutti SK, Costourous N 2004 Using gene expression profiling to differentiate benign versus malignant thyroid tumors. Cancer Res 64:2898-2903
40. Führer D, Holzapfel HP, Wonerow P, Paschke R 1996 Constitutively activating mutations of the thyrotropin receptor and thyroid disease. Eur J Med Res 1:460-464
41. Parma J, Duprez L, Van Sande J, Hermans J, Rocmans P, Van Vliet G, Costagliola S, Rodien P, Dumont JE, Vassart G 1997 Diversity and prevalence of somatic mutations in the thyrotropin receptor and Gsα genes as a cause of toxic thyroid adenomas. J Clin Endocrinol Metab 82:2695-2701
42. Trülzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F, Führer D, Paschke R 2001 Detection of thyroid-stimulating hormone receptor and Gsα mutations: in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med 78:684-691
43. Krohn K, Führer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R 2005 Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 26:504-524
44. Brown LM, Helmke SM, Hunsucker SW, Netea-Maier RT, Chiang SA, Heinz DE, Shroyer KR, Duncan MW, Haugen BR 2006 Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue. Mol Carcinog 45:613-626
45. Netea-Maier RT, Hunsucker SW, Hoevenaars BM, Helmke SM, Slootweg PJ, Hermus AR, Haugen BR, Duncan MW 2008 Discovery and validation of protein abundance differences between follicular thyroid neoplasms. Cancer Res 68:1572-1580
46. Krause K, Karger S, Schierhorn A, Poncin S, Many MC, Fuhrer D 2007 Proteomic profiling of cold thyroid nodules. Endocrinology 148:1754-1763
47. Wang Y, Hou P, Yu H, Wang W, Ji M, Zhao S, Yan S, Sun X, Liu D, Shi B, Zhu G, Condouris S, Xing M 2007 High prevalence and mutual exclusivity of genetic alterations in the PI3K/Akt pathway in thyroid tumors. J Clin Endocrinol Metab 92:2387-2390
48. Moretz 3rd WH, Gourin CG, Terris DJ, Xia ZS, Liu Z, Weinberger PM, Chin E, Adam BL 2008 Detection of papillary thyroid carcinoma with serum protein profile analysis. Arch Otolaryngol Head Neck Surg 134:198-202
49. Wang JX, Yu JK, Wang L, Liu QL, Zhang J, Zheng S 2006 Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma. Proteomics 6:5344-5349
50. Suriano R, Lin Y, Ashok BT, Schaefer SD, Schantz SP, Geliebter J, Tiwari RK 2006 Pilot study using SELDI-TOF-MS based proteomic profile for the identification of diagnostic biomarkers of thyroid proliferative diseases. J Proteome Res 5:856-861
51. Krohn K, Stricker I, Emmrich P, Paschke R 2003 Cold thyroid nodules show a marked increase in proliferation markers. Thyroid 13:569-575
52. Delys L, Detours V, Franc B, Thomas G, Bogdanova T, Tronko M, Libert F, Dumont JE, Maenhaut C 2007 Gene expression and the biological phenotype of papillary thyroid carcinomas. Oncogene 26:7894-7903
53. Linkov F, Ferris RL, Yurkovetsky Z, Marrangoni A, Velikokhatnaya L, Gooding W, Nolan B, Winans M, Siegel ER, Lokshin A, Stack BC 2008 Multiplex analysis of cytokines as biomarkers that differentiate benign and malignant thyroid diseases. Proteomics Clin Appl 2:1575-1585
54. Greaves TS, Olvera M, Florentine BD, Raza AS, Cobb CJ, Tsao-Wei DD, Groshen S, Singer P, Lopresti J, Martin SE 2000 Follicular lesions of thyroid: a 5-year fine-needle aspiration experience. Cancer 90:335-341
55. Hood BL, Darfler MM, Guiel TG, Furusato B, Lucas DA, Ringeisen BR, Sesterhenn IA, Conrads TP, Veenstra TD, Krizman DB 2005 Proteomic analysis of formalin-fixed prostate cancer tissue. Mol Cell Proteomics 4:1741-1753
56. Hwang SI, Thumar J, Lundgren DH, Rezaul K, Mayya V, Wu L, Eng J, Wright ME, Han DK 2007 Direct cancer tissue proteomics: a method to identify candidate cancer biomarkers from formalin-fixed paraffin-embedded archival tissues. Oncogene 26:65-76
57. Lundgren DH, Eng J, Wright ME, Han DK 2003 PROTEOME-3D: an interactive bioinformatics tool for large-scale data exploration and knowledge discovery. Mol Cell Proteomics 2:1164-1176
58. Berger K, Wissmann D, Ihling C, Kalkhof S, Beck-Sickinger A, Sinz A, Paschke R, Führer D 2004 Quantitative proteome analysis in benign thyroid nodular disease using the fluorescent ruthenium II tris (bathophenanthroline disulfonate) stain. Mol Cell Endocrinol 227:21-30